Literature DB >> 17292694

A pilot study of cognitive-behavioral therapy of insomnia in people with mild depression.

Daniel J Taylor1, Kenneth L Lichstein, Jeremiah Weinstock, Stacy Sanford, Jeff R Temple.   

Abstract

In some cases, insomnia and depression may have a reciprocal relationship, in which each aggravates and maintains the other. To test the hypothesis that reduction of insomnia would result in reduction of depression in patients (N=10) with both disorders, a repeated-measures design was used comparing depression and insomnia levels before and after 6 sessions of cognitive-behavioral therapy of insomnia. Posttreatment, 100% of completers (n=8) had a normalized sleeping pattern, and 87.5% had normalized depression scores. Significant posttreatment improvement was seen in sleep onset latency (-31 min), wake time after sleep onset (-24 min), total sleep time (+65 min), sleep efficiency (+14%), and sleep quality (+19%), which was maintained at 3-month follow-up. A decreasing trend occurred in depression scores from pre- to posttreatment, which reached significance at 3-month follow-up. Intent-to-treat analyses showed similar results.

Entities:  

Mesh:

Year:  2006        PMID: 17292694     DOI: 10.1016/j.beth.2006.04.002

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  48 in total

1.  Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.

Authors:  Michael E Thase; Harald Murck; Anke Post
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.

Authors:  Colleen E Carney; Jack D Edinger; Maragatha Kuchibhatla; Angela M Lachowski; Olya Bogouslavsky; Andrew D Krystal; Colin M Shapiro
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

3.  Social rhythm regularity moderates the relationship between sleep disruption and depressive symptoms in veterans with post-traumatic stress disorder and major depressive disorder.

Authors:  Elaine M Boland; Jennifer R Goldschmied; Monica R Kelly; Suzanne Perkins; Philip R Gehrman; Patricia L Haynes
Journal:  Chronobiol Int       Date:  2019-08-01       Impact factor: 2.877

4.  Insomnia and depression.

Authors:  Daniel J Taylor
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

5.  Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches.

Authors:  Joshua Z Tal; Sooyeon A Suh; Claire L Dowdle; Sara Nowakowski
Journal:  Curr Psychiatry Rev       Date:  2015

6.  Poor sleep quality increases symptoms of depression and anxiety in postpartum women.

Authors:  Michele L Okun; Roberta A Mancuso; Calvin J Hobel; Christine Dunkel Schetter; Mary Coussons-Read
Journal:  J Behav Med       Date:  2018-07-20

7.  Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.

Authors:  Rachel Manber; Jack D Edinger; Jenna L Gress; Melanie G San Pedro-Salcedo; Tracy F Kuo; Tasha Kalista
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

8.  Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?

Authors:  Wilfred R Pigeon; Mark Hegel; Jürgen Unützer; Ming-Yu Fan; Michael J Sateia; Jeffrey M Lyness; Cindy Phillips; Michael L Perlis
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

9.  Inadequate Sleep as a Mediating Variable between Exposure to Interparental Violence and Depression Severity in Adolescents.

Authors:  Sara Nowakowski; HyeJeong Choi; Jessica Meers; Jeffrey R Temple
Journal:  J Child Adolesc Trauma       Date:  2016-06

10.  Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?

Authors:  Alexandre Y Dombrovski; Jill M Cyranowski; Benoit H Mulsant; Patricia R Houck; Daniel J Buysse; Carmen Andreescu; Michael E Thase; Alan G Mallinger; Ellen Frank
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.